🇺🇸 FDA
Patent

US 8163548

Recombinant bicistronic flaviviruses and methods of use thereof

granted A61KA61K2039/5256A61K39/00

Quick answer

US patent 8163548 (Recombinant bicistronic flaviviruses and methods of use thereof) held by The Regents of the University of California expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/5256, A61K39/00, A61K48/00, A61P